Idaho
CNS clinical trials in Idaho
19 CNS studies are recruiting participants at sites in 6 cities across Idaho as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Idaho city with a recruiting study
By research area: Depression (7), Epilepsy (4), Migraine (4), Parkinson's Disease (3), Multiple Sclerosis (1).
Boise (11), Meridian (3), Coeur d'Alene (2), Idaho Falls (1), Post Falls (1), Saint Maries (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Idaho
Basic details from each study's public record (the 12 most recently updated of 19). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Maternal Stress on Human Milk and Infant Outcomes
- No phase
- Ages 18 to 50
- Female participants
- Sponsor
- University of Idaho
- Recruiting in
- Coeur d'Alene
- Registry record
- NCT04821544 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Boise
- Registry record
- NCT06748222 · updated
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Saint Maries
- Registry record
- NCT07716098 · updated
Study of ALTO-300 in MDD
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Alto Neuroscience
- Recruiting in
- Boise
- Registry record
- NCT05922878 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Idaho on ClinicalTrials.gov.
Parkinson's disease: recently updated in Idaho
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Boston Scientific Corporation
- Recruiting in
- Boise
- Registry record
- NCT02071134 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Boise
- Registry record
- NCT06841354 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Post Falls
- Registry record
- NCT06623422 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Idaho on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in Idaho
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Recruiting in
- Coeur d'Alene
- Registry record
- NCT06433752 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Idaho on ClinicalTrials.gov.
Epilepsy: recently updated in Idaho
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Recruiting in
- Boise
- Registry record
- NCT07563881 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Recruiting in
- Boise
- Registry record
- NCT05667142 · updated
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Recruiting in
- Boise
- Registry record
- NCT05716100 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Idaho on ClinicalTrials.gov.
Migraine: recently updated in Idaho
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Boise
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Idaho on ClinicalTrials.gov.
Ask about studies in Idaho
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections